Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Otilonium Bromide: Practical Research Workflows
2026-08-24
Otilonium Bromide is an antimuscarinic agent for controlled interrogation of cholinergic signaling in smooth muscle and cellular neuroscience models. This workflow-focused guide covers stock preparation, functional assays, assay controls, troubleshooting, and how structure-based screening concepts can improve experimental decision-making without overstating antiviral relevance.
-
EPZ5676: Selective DOT1L Inhibitor Research Guide
2026-08-24
EPZ5676 is a potent and selective DOT1L inhibitor that targets the SAM-binding pocket and suppresses H3K79 methylation. Its biochemical potency, MLL-fusion leukemia activity, and emerging immunoepigenetic relevance support use in mechanistic epigenetics and leukemia research, not direct clinical substitution.
-
Niclosamide B2283: Reliable STAT3 Cell Assays
2026-08-23
Learn how Niclosamide (SKU B2283) can support reproducible STAT3, viability, apoptosis, and cell-cycle experiments. This scenario-based guide covers formulation, dose selection, orthogonal readouts, interpretation, and practical product selection.
-
Annexin V Workflow for Preeclampsia Models
2026-08-22
Build a calcium-dependent apoptosis assay around Annexin V to distinguish phosphatidylserine externalization from later membrane failure in trophoblast–T-cell models. The workflow extends recent preeclampsia research by adding a direct, quantitative cell-death readout to studies of placenta-derived exosomes and immune tolerance.
-
QX77: From CMA Mechanism to Translational Strategy
2026-08-22
QX77 offers a pathway-resolved approach to autophagy research by increasing LAMP2A expression, supporting chaperone-mediated autophagy, and restoring Rab11-associated trafficking. This thought-leadership analysis connects those properties with findings from an ETS1/SENP2/HSPA8/FUNDC1 study of mitophagy in bronchopulmonary dysplasia, while distinguishing mechanistic opportunity from translational evidence. It also provides practical assay guidance for researchers working across lysosomal receptor regulation, stem cell biology research, and disease-relevant autophagy models.
-
Phillygenin Mechanisms in Diabetic Nephropathy
2026-08-21
A study in Phytomedicine identifies phillygenin as a preclinical intervention for diabetic nephropathy and links its renal protective effects to suppression of TLR4/MyD88/NF-κB inflammation and restoration of PI3K/AKT/GSK3β-associated survival signaling. Its integrated podocyte, transcriptomic, biochemical, and db/db mouse design provides a useful framework for interpreting inflammation, apoptosis, and proteinuria in diabetic kidney disease.
-
LY294002 for PI3K/Akt/mTOR Assay Design
2026-08-20
LY294002 provides a reversible, cell-permeable way to interrogate class I PI3K signaling across cancer, autophagy, and inflammatory cell models. This guide translates the ajugol gouty-arthritis study into practical assay designs, controls, dose planning, and troubleshooting strategies.
-
Bazedoxifene Blocks Hemozoin Formation in Malaria
2026-08-20
Sudhakar and colleagues show that bazedoxifene, a third-generation selective estrogen receptor modulator, inhibits susceptible and drug-resistant Plasmodium falciparum and reduces Plasmodium berghei infection in female mice. The study links activity to early ring-stage vulnerability and impaired hemozoin formation, supporting drug repurposing while highlighting sex-specific differences in in vivo efficacy.
-
TH287 Radiosensitizes Castration-Resistant Prostate Cancer
2026-08-19
The reference study shows that TH287 increases the response of PC-3 and DU-145 castration-resistant prostate cancer cells to ionizing radiation, with the strongest effect when radiation follows drug exposure by 12 hours. Its combination of viability, apoptosis, protein-expression, and cell-cycle analyses supports MTH1 inhibition as a timing-sensitive radiosensitization strategy, while the in vitro design limits direct clinical extrapolation.
-
Tamoxifen B5965: Reliable Cell Assay Workflows
2026-08-19
Learn how Tamoxifen (SKU B5965) can support reproducible viability, proliferation, cytotoxicity, and CreER-mediated gene knockout workflows. This scenario-based guide covers mechanism-aware assay design, solubility, controls, interpretation, and practical vendor selection.
-
T7 RNA Polymerase for RNA Assay Workflows
2026-08-18
T7 RNA Polymerase enables defined, promoter-directed RNA production from linearized plasmids and PCR templates for probes, translation studies, RNAi, and vaccine research. This guide connects practical transcription control with the DDX21–NAT10 findings reported in colorectal cancer, while highlighting assay boundaries and troubleshooting strategies.
-
Gramine for Ferroptosis and TNBC Research
2026-08-18
Gramine is a research-grade ferroptosis inducer for connecting triple-negative breast cancer cell viability with CUL3–MTDH signaling. This practical guide covers solvent handling, dose-response design, target-engagement assays, rescue experiments, and troubleshooting for reproducible cancer biology research.
-
BHQ: Selective SERCA Inhibitor for Calcium Research
2026-08-17
2,5-di-tert-butylbenzene-1,4-diol (BHQ) is a selective SERCA inhibitor used to study endoplasmic reticulum calcium storage, calcium signaling, and cellular stress. A 2025 in vivo study linked BHQ-mediated SERCA inhibition with enhanced hematopoietic stem cell mobilization through the CaMKII-STAT3-CXCR4 pathway.
-
TH287 Radiosensitizes CRPC Cells to Ionizing Radiation
2026-08-17
The 2026 reference study identifies a schedule-dependent radiosensitizing effect of TH287 in PC-3 and DU-145 castration-resistant prostate cancer cells. Its central finding is that administering ionizing radiation 12 hours after MTH1 inhibition produced stronger survival suppression, apoptosis, and cell-cycle disruption than later radiation schedules.
-
AMG 9810: TRPV1 Antagonist Workflow Guide
2026-08-16
Build cleaner TRPV1 experiments with AMG 9810, from capsaicin-evoked calcium imaging to CGRP secretion assays. This guide combines practical dosing, solvent controls, metabolic-stress safeguards, and troubleshooting for pain mechanism research.